Responding to domestic abuse guideline
Covering information for practitioners on identifying and responding to potential domestic violence and abuse victims
UKHSA staff with symptoms of a respiratory infection guideline
Covering the management of healthcare staff with symptoms of a respiratory infection, including COVID-19 and positive COVID-19 test results
NICE care for people experiencing homelessness guideline
Covering ways to improve access to, and engagement with, health and social care services for people experiencing homelessness
Let’s talk about weight guideline
Support your patients to manage their weight by initiating a conversation. This is a step-by-step guide to brief interventions with adults.
NICE tobacco guideline
A new single source for tobacco guidance from NICE, covering promoting quitting, and treating tobacco dependence and tobacco-dependent pregnant women
NHS blood testing guidance
Covering best practice guidance and practical advice for optimising use of blood testing
PHE influenza immunisation policy
This summary provides comprehensive guidance about flu immunisation for public health professionals
NICE shared decision making guideline
Guidance on employing the collaborative process of involving a person and their healthcare professional to reach joint care decisions in primary care
PHE inadvertent vaccination in pregnancy guideline
This concise and useful summary covers monitoring of women vaccinated in pregnancy or shortly before conception
AWMSG prescribing guide
Guidance on solving prescribing dilemmas, including (but not limited to) clinical responsibility, prescribing duration, and complementary therapies
Resource hub
Having a smear test—what is it about?
Supporting nurse mentors to reduce the barriers to implementing alcohol Interventions and Brief Advice (IBA) in primary care
- Previous
- Next
Educational resources
Liraglutide 6 mg/ml solution for injection in pre-filled pen (Saxenda®) SMC2455
Information intended for UK healthcare professionals only. The production of this Guidelines card has been commissioned by Novo Nordisk Limited.
View Saxenda® (liraglutide 3 mg) Great Britain and Northern Ireland prescribing information and adverse event reporting information.
UK22SX00249
Date of preparation: June 2022
Management of obesity in primary care: a Guidelines algorithm
Information intended for UK healthcare professionals only. These videos have been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines approached Novo Nordisk Limited to fund the production of these videos.
Date of preparation: December 2021
Managing obesity in primary care
This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.